dc.contributor.author | Likhitpanichkul, Morakot | |
dc.contributor.author | Kim, Yesul | |
dc.contributor.author | Torre, Olivia M. | |
dc.contributor.author | See, Eugene | |
dc.contributor.author | Kazezian, Zepur | |
dc.contributor.author | Pandit, Abhay | |
dc.contributor.author | Hecht, Andrew C. | |
dc.contributor.author | Iatridis, James C. | |
dc.date.accessioned | 2018-09-20T16:14:35Z | |
dc.date.available | 2018-09-20T16:14:35Z | |
dc.date.issued | 2015-09-01 | |
dc.identifier.citation | Likhitpanichkul, Morakot; Kim, Yesul; Torre, Olivia M. See, Eugene; Kazezian, Zepur; Pandit, Abhay; Hecht, Andrew C.; Iatridis, James C. (2015). Fibrin-genipin annulus fibrosus sealant as a delivery system for anti-tnfα drug. The Spine Journal 15 (9), 2045-2054 | |
dc.identifier.issn | 1529-9430 | |
dc.identifier.uri | http://hdl.handle.net/10379/12454 | |
dc.publisher | Elsevier BV | |
dc.relation.ispartof | The Spine Journal | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Ireland | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ie/ | |
dc.subject | intervertebral disc | |
dc.subject | annulus fibrosus repair | |
dc.subject | biomaterials | |
dc.subject | anti-inflammatory drug | |
dc.subject | drug delivery | |
dc.subject | spinal injection | |
dc.subject | intervertebral disc degeneration | |
dc.subject | herniation-induced sciatica | |
dc.subject | tumor-necrosis-factor | |
dc.subject | issls prize winner | |
dc.subject | lumbar disc | |
dc.subject | follow-up | |
dc.subject | controlled-trial | |
dc.subject | repair | |
dc.subject | infliximab | |
dc.subject | expression | |
dc.title | Fibrin-genipin annulus fibrosus sealant as a delivery system for anti-tnfα drug | |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.spinee.2015.04.026 | |
dc.local.publishedsource | http://europepmc.org/articles/pmc4550557?pdf=render | |
nui.item.downloads | 0 | |